Sort
141,003 grants matching “cytokine”
Mechanism of Latency of Herpes Simplex Virus
$1,319,685Priscilla A Schaffer · Beth Israel Deaconess Medical Center · P01 · FY2006 · NS
Dupilumab in the Treatment of Pediatric Alopecia Areata
$1,319,400Emma Guttman · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · AI
UNIVERSITY OF PITTSBURGH BRAIN TRAUMA RESEARCH CENTER
$1,319,368University Of Pittsburgh At Pittsburgh · P50 · FY2003 · NS
A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
$1,319,208Beth Diane Kirkpatrick · University Of Vermont & St Agric College · U01 · FY2020 · AI
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$1,318,649John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,318,361Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Chronic DTH and IFN-gamma in Human Graft Arterioscleros*
$1,317,930Yale University · P01 · FY2004 · HL
Obesity, related comorbidities, and breast cancer outcomes in African Americans
$1,317,553Elisa V Bandera · Rbhs -Cancer Institute Of New Jersey · R01 · FY2016 · CA
Protein Structure
$1,317,450Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
T-cell Transformation by Oncoviruses
$1,317,296Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
VIPS: Vascular Effects of Infection in Pediatric Stroke
$1,316,736Heather J Fullerton · University Of California, San Francisco · R01 · FY2012 · NS
Heat Shock Protein and Thermal Therapy of Cancer
$1,316,642Roswell Park Cancer Institute Corp · P01 · FY2003 · CA
Transplant Arteriosclerosis: Viral and Host Mechanism
$1,316,615Stanford University · P01 · FY2003 · AI
IBD--GENETIC AND IMMUNOPATHOLOGIC MECHANISMS
$1,316,231Cedars-Sinai Medical Center · P01 · FY2004 · DK
Glycolipid Presentation by CD1d
$1,315,584Albert S. Bendelac · University Of Chicago · P01 · FY2009 · AI
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
$1,315,081Nancy J Olsen · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2021 · AR
Lung Cancer Health Disparities
$1,314,875Brid Ryan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
$1,314,516Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Receptor -directed therapy
$1,314,117John Janik · Basic Sciences · Z01 · FY2007 · CA
Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients
$1,314,026Kimberly Anne Johnston · Innovative Biotherapies, Inc. · R44 · FY2024 · HL
CTO1681 to prevent and mitigate cytokine release syndrome in multiple myeloma patients receiving CAR T-cell therapy
$1,313,567Arthur P Bertolino · Cytoagents, Inc. · R44 · FY2025 · CA
Clinical Trials of Patients with AIDS-Related Malignancies
$1,313,488Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Clinical Trials of Patients with AIDS-Related Malignancies
$1,313,319Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Molecular mechanisms of liver injury, repair, and immunity
$1,313,140Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
The Danger Model 2: how tissues control Immunity
$1,312,470Polly C Matzinger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI